Futibatinib is an FGFR inhibitor. It’s made to treat cholangiocarcinoma, which is often linked to FGFR2 fusions. It stops the FGFR signaling pathway.
You can get this drug in tablet form, and it’s 4 mg strong. You’re supposed to take 20 mg a day, and that’s five tablets. The product comes in bottles with 28 tablets in each.
